Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| LIGAND PHARMACEUTICALS INC | 26,707 | reported | 27 May 2026 | tx 105+215,909−91,008 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 May 2026 | EXERCISE | LIGAND PHARMACEUTICALS INC | 764 | 63.62 USD | |
| 27 May 2026 | EXERCISE | LIGAND PHARMACEUTICALS INC | 972 | 52.84 USD | |
| 27 May 2026 | EXERCISE | LIGAND PHARMACEUTICALS INC | 972 | 0.00 USD | deriv |
| 27 May 2026 | EXERCISE | LIGAND PHARMACEUTICALS INC | 764 | 0.00 USD | deriv |
| 02 Mar 2026 | GRANT_AWARD | LIGAND PHARMACEUTICALS INC | 4,933 | 0.00 USD | |
| 02 Mar 2026 | GRANT_AWARD | LIGAND PHARMACEUTICALS INC | 23,527 | 0.00 USD | deriv |
| 11 Mar 2026 | EXERCISE | LIGAND PHARMACEUTICALS INC | 2,405 | 92.65 USD | |
| 11 Mar 2026 | SALE | LIGAND PHARMACEUTICALS INC | 3,057 | 225.00 USD | |
| 11 Mar 2026 | EXERCISE | LIGAND PHARMACEUTICALS INC | 2,405 | 0.00 USD | deriv |
| 04 Mar 2026 | SALE | LIGAND PHARMACEUTICALS INC | 950 | 201.73 USD | |
| 04 Mar 2026 | SALE | LIGAND PHARMACEUTICALS INC | 3,413 | 208.80 USD | |
| 04 Mar 2026 | SALE | LIGAND PHARMACEUTICALS INC | 2,457 | 207.91 USD | |
| 04 Mar 2026 | EXERCISE | LIGAND PHARMACEUTICALS INC | 1,607 | 58.49 USD | |
| 04 Mar 2026 | EXERCISE | LIGAND PHARMACEUTICALS INC | 466 | 80.72 USD | |
| 04 Mar 2026 | SALE | LIGAND PHARMACEUTICALS INC | 699 | 198.71 USD | |
| 04 Mar 2026 | SALE | LIGAND PHARMACEUTICALS INC | 53 | 200.08 USD | |
| 04 Mar 2026 | SALE | LIGAND PHARMACEUTICALS INC | 698 | 201.09 USD | |
| 04 Mar 2026 | SALE | LIGAND PHARMACEUTICALS INC | 697 | 202.79 USD | |
| 04 Mar 2026 | SALE | LIGAND PHARMACEUTICALS INC | 668 | 203.63 USD | |
| 04 Mar 2026 | SALE | LIGAND PHARMACEUTICALS INC | 743 | 204.74 USD | |
| 04 Mar 2026 | SALE | LIGAND PHARMACEUTICALS INC | 1,457 | 205.79 USD | |
| 04 Mar 2026 | SALE | LIGAND PHARMACEUTICALS INC | 1,588 | 206.89 USD | |
| 04 Mar 2026 | EXERCISE | LIGAND PHARMACEUTICALS INC | 1,607 | 0.00 USD | deriv |
| 04 Mar 2026 | EXERCISE | LIGAND PHARMACEUTICALS INC | 466 | 0.00 USD | deriv |
| 15 Feb 2026 | TAX_WITHHOLDING | LIGAND PHARMACEUTICALS INC | 1,026 | 183.83 USD |